Should dapagliflozin be discontinued before a surgical procedure?
Fuente:
Zenodo
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Recurso digital |
| Publié: |
Zenodo
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1866901470934204416 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Dapagliflozin is commonly withheld 3 to 4 days before surgery to reduce the risk of euglycemic diabetic ketoacidosis, based on the latest evidence and guidelines. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18408563 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Should dapagliflozin be discontinued before a surgical procedure? Tripdatabase dapagliflozin discontinued before surgical procedure Dapagliflozin is commonly withheld 3 to 4 days before surgery to reduce the risk of euglycemic diabetic ketoacidosis, based on the latest evidence and guidelines. |
| title | Should dapagliflozin be discontinued before a surgical procedure? |
| topic | dapagliflozin discontinued before surgical procedure |
| url | https://doi.org/10.5281/zenodo.18408563 |